Complete coverage on

GlaxoSmithKline plc

A medical group in Argentina is asking for more drug-testing regulations in the South American country after a officials fined pharmaceutical company GlaxoSmithKline for alleged irregularities in a pediatric pneumonia vaccine trial.

Latest Stories

Malaria vaccine trial promisingupdated: Wed Oct 19 2011 11:27:00

A trial study finds a malaria vaccine appears to cut infections by half in a one-year period.

CNNMoney: Glaxo to pay $750 million penaltyupdated: Wed Oct 27 2010 11:27:00

SB Pharmaco, a unit of health care giant GlaxoSmithKline, pleaded guilty to charges it sold "adulterated" drugs made at a now-closed plant in Puerto Rico, federal regulators said Tuesday.

Split decision from FDA panel on Avandiaupdated: Thu Jul 15 2010 07:55:00

A Food and Drug Administration committee delivered a split verdict on the diabetes drug Avandia on Wednesday, with most members voting to leave it on the market but recommending different changes in how it's prescribed.

FDA panel split on Avandiaupdated: Thu Jul 15 2010 07:55:00

FDA officials will decide the ultimate fate of the diabetes drug Avandia. CNN's Dr. Sanjay Gupta reports.

CNNMoney: FDA panel split on Avandia decisionupdated: Wed Jul 14 2010 17:14:00

A Food and Drug Administration committee delivered a split verdict on the diabetes drug Avandia on Wednesday, with most members voting to leave it on the market but recommending changes in how it's prescribed.

Fortune: Pharma and biotech: is there love?updated: Mon May 10 2010 11:53:00

For at least a decade, anyone following the life sciences industry has noticed two naked truths.

CNNMoney: Senators challenge safety of GlaxoSmithKline's Avandiaupdated: Mon Feb 22 2010 16:42:00

The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, a Senate committee report released Saturday says.

Senate report links diabetes drug Avandia to heart attacksupdated: Sat Feb 20 2010 16:39:00

The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released Saturday.

Global swine flu deaths top 1,100updated: Mon Aug 24 2009 13:12:00

More than 1,100 people worldwide have died from swine flu since it emerged in Mexico and the U.S. in April, according to the latest figures from the World Health Organization.

Swine flu drug sales soar amid stockpilingupdated: Thu Jul 23 2009 00:58:00

Sales of the flu drug Relenza shot up 1,900 percent from a year ago as governments around the world stockpiled in preparation for a swine flu pandemic, drugmaker GlaxoSmithKline said Wednesday.

H1N1 vaccine testedupdated: Thu Jul 23 2009 00:58:00

Australia starts vaccine trials for the H1N1 virus. SBS's Jenny Lavelle reports.

CNNMoney: Layoffs hit every cornerupdated: Sat Nov 08 2008 11:40:00

The first week of November has been brutal for the job market, with nearly 15,000 announced job cuts from a slew of companies across multiple industries.

CNNMoney: Wall Street set for a volatile dayupdated: Fri Apr 04 2008 09:20:00

Stock futures fluctuated early Friday after a key report on the U.S. labor market showed a bigger-than-expected job loss in March. UK to Force Drugmakers to Share Infoupdated: Mon Mar 24 2008 22:25:00

Britain plans to force pharmaceutical companies to share more information with regulators about clinical trials after an investigation recently concluded that GlaxoSmithKline PLC deliberately withheld information about an antidepressant

GlaxoSmithKline earnings dropupdated: Thu Feb 07 2008 21:38:00

CNN's Charles Hodson talks with GlaxoSmithKline CEO Jean-Pierre Garnier about his company's recent drop in earnings.

Man invents cancer machineupdated: Mon Dec 17 2007 07:49:00

Dr. Sanjay Gupta profiles man with no medical experience who invented a machine meant to cure cancer.

Parents must vaccinate kidsupdated: Fri Nov 23 2007 11:07:00

CNN's Elizabeth Cohen reports on Maryland families who were ordered to have their kids vaccinated or face prosecution.

Deadly cold virusupdated: Mon Nov 19 2007 13:39:00

CNN's Dr. Sanjay Gupta reports on a new strain of the common cold virus that has killed at least 10 people.

CNNMoney: HIV drug market mutatesupdated: Mon Nov 19 2007 13:39:00

The market for treatment of human immunodeficiency virus, or HIV, is mutating as rapidly as the virus itself, and drug industry heavyweight GlaxoSmithKline could find its lead position in jeopardy.

Diabetes drug market: Lizard spit and bongsupdated: Wed Oct 31 2007 09:54:00

America's 20 million-plus diabetics mean dollar signs for drug companies that sell a slew of new products, including a successful drug based on the saliva of a Gila monster, and a failed inhalation device that's been compared to a "bong."

CNNMoney: Glaxo's cancer vaccine Ok'd in Europeupdated: Mon Sep 24 2007 05:21:00

Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.

CNNMoney: Stock rally spoiled by subprime, oilupdated: Tue Jul 31 2007 04:16:00

Stocks suffered a steep selloff Tuesday afternoon after a bold start with the Dow industrials falling nearly 150 points on more subprime mortgage woes and record-high oil prices.

CNNMoney: Bull run loses steamupdated: Tue Jul 31 2007 02:03:00

Early gains on Wall Street all but evaporated in Tuesday afternoon trading, as investors eyed new credit market developments and the latest corporate earnings.

CNNMoney: Glaxo prepares for face-to-face with FDAupdated: Fri Jul 20 2007 01:57:00

GlaxoSmithKline is getting ready for a face-to-face with the FDA about its diabetes drug Avandia, which has been on the hot seat since a study blamed the drug for increasing the risk of heart attack. Medical Expert to Testify Against Glaxoupdated: Wed Jun 06 2007 18:05:00

The controversy surrounding GlaxoSmithKline's diabetes drug Avandia mounted Wednesday as a medical expert prepared to tell lawmakers the British drug maker threatened him with legal action when he first raised questions about the treatment's safety FDA Declines Cancer Vaccine Reviewupdated: Thu May 31 2007 18:10:00

GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix

CNNMoney: Merck, Lilly could benefit from Avandia flapupdated: Tue May 22 2007 12:39:00

The recently published study results that link GlaxoSmithKline's blockbuster diabetes drug Avandia to heart attacks could shift market share to rivals Merck, Lilly and Amylin, despite questions surrounding the data, analysts say.

CNNMoney: Glaxo tries to expand top-selling drugupdated: Mon Apr 30 2007 11:45:00

The British drugmaker GlaxoSmithKline is trying wean just a little more revenue from its top-selling blockbuster Advair, and its ability to do so depends on whether FDA experts believe the allergy drug merits a larger patient population.

CNNMoney: Glaxo readies challenge to Merck monopolyupdated: Wed Mar 14 2007 11:56:00

GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.

CNNMoney: FDA approves Glaxo's breast cancer drugupdated: Tue Mar 13 2007 09:28:00

The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.

CNNMoney: FDA likely to approve Glaxo breast cancer drugupdated: Mon Mar 12 2007 11:26:00

The Food and Drug Administration is expected to approve a breast cancer treatment from GlaxoSmithKline on Tuesday, analysts say.

CNNMoney: FDA experts to vote on first bird flu vaccineupdated: Thu Feb 22 2007 15:10:00

Worried about bird flu? If Sanofi has its way, America could soon be getting its first FDA-approved vaccine.

CNNMoney: Dieters have Alli in weight-loss warupdated: Thu Feb 08 2007 12:07:00

The FDA's decision to grant over-the-counter status to GlaxoSmithKline's weight loss drug Alli could have big implications on national health, but the drug is not a miracle cure, experts said.

CNNMoney: Feds award bird flu vaccine contracts to Novartis, Glaxoupdated: Wed Jan 17 2007 12:28:00

The U.S. government awarded Novartis and GlaxoSmithKline contracts worth more than $100 million to develop vaccines to protect against the possibility of a bird flu pandemic, the drug companies said.

CNNMoney: Competition looming for Amgen, Glaxo with blood clot drugsupdated: Mon Dec 11 2006 13:02:00

The biotech Amgen and the drugmaker GlaxoSmithKline announced similar results for experimental blood-clotting drugs and could find themselves locking horns in the near future.

70 percent of dieters go solo, with no doctor, survey findsupdated: Mon Nov 06 2006 14:42:00

Besides extra pounds, dieters also seem to carry a hefty independent streak. A survey finds that 70 percent of Americans who are trying to lose weight are following their own diet plans and have no interest in seeking a doctor's help.

CNNMoney: Big Pharma: Bad time to botch a blockbusterupdated: Fri Oct 27 2006 13:31:00

Hey Big Pharma, listen up: this is NOT the time to be dropping the ball on a blockbuster.

CNNMoney: Radio tags not yet tuning out fake drugsupdated: Thu Oct 12 2006 12:01:00

Imagine this: a worldwide network of radio-tagged pharmaceuticals, weeding out the multi-billion dollar counterfeit drug market with a universal security system.

Fortune: GlaxoSmithKline ranks No. 143 on FORTUNE's 2006 Global 500updated: Thu Sep 21 2006 12:35:00

GlaxoSmithKline ranks no. 143 on FORTUNE's Global 500 this year, with $39.4 billion in revenues, up 5.5% from the previous year. The Brentford, Britain-based company was ranked no. 122 on the 2005 list. Its 2005 profits were $8.8 billion, up 8.1% from a year earlier. 2005 was a banner year for most Global 500 companies.

Fortune: Patently unfairupdated: Fri Sep 08 2006 06:01:00

On the top floor of a drab apartment building on the edge of New Delhi, Ram Meher, 35, is taking his AIDS medicine, as he has every day for the past three years. Meher is a struggling wheat and sug...

First success reported with small-dose bird flu vaccineupdated: Fri Jul 28 2006 10:57:00

A British company announced this week that it has developed the first effective small-dose bird flu vaccine.

Glaxo claims bird flu breakthroughupdated: Fri Jul 28 2006 01:35:00

A British company has announced that it has developed the first effective small-dose bird flu vaccine.

CNNMoney: Merck cancer vaccine may get Glaxo challengeupdated: Mon Jun 05 2006 09:58:00

Vital protection against cervical cancer could soon be made available, not just from Merck but also from GlaxoSmithKline, providing life-saving potential for women while feeding a competitive atmosphere for the drug giants.

CNNMoney: Favorable results for Glaxo drugupdated: Sat Jun 03 2006 09:22:00

Tykerb, an experimental new drug from GlaxoSmithKline, significantly slowed the spread of breast cancer in clinical trials, according to study results released Saturday.

CNNMoney: Suicide label unlikely to squeeze Glaxo salesupdated: Fri May 12 2006 12:59:00

GlaxoSmithKline added the increased risk of suicide for young adults to its Paxil label this week, but the antidepressant is past its prime in terms of sales so it's unlikely to hurt the drugmaker.

CNNMoney: Drugmakers get $1 billion for bird flu vaccineupdated: Thu May 04 2006 10:40:00

The U.S. Department of Health and Human Services awarded $1 billion to drugmakers, including nearly $700 million to GlaxoSmithKline, Novartis and MedImmune, to help them develop a faster method of producing an influenza vaccine to better protect the nation against the possibility of a pandemic.

Fortune: Sirna to ally with GlaxoSmithKlineupdated: Mon Apr 03 2006 17:10:00

It's been quite a week for Sirna Therapeutics -- and it's still only Monday.

CNNMoney: Vaccine could end children's ear infectionsupdated: Fri Mar 03 2006 08:22:00

GlaxoSmithKline Plc has developed a new vaccine that could help prevent ear infections, a widespread problem for children, according to a study published in the British medical journal Lancet.

CNNMoney: Glaxo ramps up warning on Paxil labelupdated: Thu Dec 08 2005 11:36:00

Paxil, a blockbuster antidepressant from GlaxoSmithKline, increases the risk of babies' heart defects in pregnant mothers, the Food and Drug Administration said Thursday.

Fortune: THE COMING STORM OVER A CANCER VACCINEupdated: Mon Oct 31 2005 00:01:00

Eliav Barr has popped the champagne. After a decade of development, his team at Merck has just finished presenting the clinical-trial results on the company's cervical cancer vaccine, Gardasil, to ...

CNNMoney: Glaxo pushes for bird flu vaccine by '06updated: Thu Oct 27 2005 12:35:00

GlaxoSmithKline chief executive officer Jean-Pierre Garnier said on Thursday that he intends to complete tests for a bird flu vaccine within the next two years.

CNNMoney: Glaxo's new drug may save migraine salesupdated: Wed Oct 12 2005 12:06:00

GlaxoSmithKline will lose patent protection on a blockbuster migraine treatment in three years, but may have figured out how to protect sales by spinning off the drug as a new combination product, analysts say.

CNNMoney: Drugmakers meet with Bush, offer help.updated: Mon Oct 10 2005 15:39:00

GlaxoSmithKline said it has taken steps to ramp up vaccine production to protect against avian flu following last week's meeting at the White House with President Bush, and other drug giants that participated in the meeting have offered to help.

CNNMoney: Glaxo bets on experimental cancer drugupdated: Thu Aug 18 2005 11:08:00

GlaxoSmithKline has thrown its big pharma weight behind an experimental anti-cancer drug being tested by Human Genome Sciences.

CNNMoney: Drugmakers struggle with AIDS drugsupdated: Wed Jul 06 2005 15:14:00

With nearly 40 million people with AIDS worldwide, why aren't drug companies pouring everything they have into a cure for what some health workers call "the disease of mass destruction?"

Fortune: WISDOM FROM BIG PHARMA'S DR. GLOOMupdated: Mon Mar 21 2005 00:01:00

You might expect GlaxoSmithKline CEO Jean-Pierre Garnier to be keeping a low profile. After all, top Glaxo antidepressants, including Paxil, are under fire for possible links to childhood suicides,...

Experts: AIDS vaccine years awayupdated: Mon Jul 12 2004 06:22:00

Scientists have played down hopes that an AIDS vaccine could be developed within the next few years.

Business 2.0: The Drug Pipeline Flows Again Tachi Yamada wrote up the ultimate Rx for GlaxoSmithKline: Making entrepreneurs out of 15,000 scieupdated: Thu Apr 01 2004 00:01:00

January 2000 still seemed like a blue-sky dream for most of the business world. But a dark cloud had already settled over the heads of Tachi Yamada and Jean-Pierre Garnier, two top executives at Sm...

Fortune: Pfizer Is Itching To Start A Drug War With Canadaupdated: Mon Mar 22 2004 00:01:00

From the looks of it, Pfizer is gearing up for a drug showdown. In late February the No. 1 drugmaker cut off two Canadian wholesalers that it said were supplying retailers who sell to Americans. It...

Money Magazine: Drugmakers Take Aim At Canadaupdated: Sat Mar 01 2003 00:01:00

At least one pharmaceutical giant is sick and tired of Americans filling prescriptions in Canada, where drugs can sell for 30% to 70% less. On Jan. 21, GlaxoSmithKline, the maker of antidepressant ...

Fortune: The World's Largest Corporations GLOBAL 500 BY THE NUMBERS A quarter of the companies on the list made less money in 2000 than iupdated: Mon Jul 23 2001 00:01:00

Coasting. That is the word that best describes the state of the world's largest corporations as they glided into 2001. Despite the bursting of the technology bubble and the deteriorating economic c...

Fortune: The Real Power in Health Care WHY DRUG COMPANIES FEAR AND LOATHE PHARMACISTSupdated: Mon Mar 29 1999 00:01:00

The medical profession, like most businesses, has a food chain. And pharmacists, like any group of highly trained professionals, aren't crazy about being plankton.

Fortune: The Year Of The Deals That Almost Got Doneupdated: Mon Nov 23 1998 00:01:00

While most of Wall Street slouches toward the holiday season, at least one part of the biz--mergers and acquisitions--has held up pretty darn well. Yes, the real blockbuster deals--Citi-Travelers, ...

Fortune: AIDS: The New Drug War BRISTOL-MYERS SQUIBB VS. GLAXO WELLCOMEupdated: Mon Apr 27 1998 00:01:00

An unexpected front has opened in the national war on AIDS: a battle for market share among the drugs used to combat the virus. Until recently the best-known "nucleoside reverse transcriptase inhib...

Fortune: A Mangled Merger HOW GLAXO AND SMITHKLINE OVERDOSED ON EGOupdated: Mon Mar 30 1998 00:01:00

It seems that deals driven by big executive egos can also be undone by them. At least that's the best line so far on why pharmaceuticals giants Glaxo Wellcome and SmithKline Beecham called off thei...

Fortune: The Fallout From Merger Maniaupdated: Mon Mar 02 1998 00:01:00

The latest: Digital and Compaq, $9.6 billion; Glaxo and SmithKline, around $70 billion. The wave of mergers just keeps rolling, one blockbuster after another. Not that we should be surprised: We ma...

Money Magazine: REDUCE YOUR PORTFOLIO RISK WITH OVERSEAS BLUE CHIPSupdated: Fri Aug 01 1997 00:01:00

Uncertain. That's the best that can be said about the outlook for the world's biggest equity markets. MONEY chief investment strategist Michael Sivy warns that U.S. stocks may pull back as much as ...


From the outside, Glaxo Wellcome, the world's largest drugmaker, looks the picture of health. Pretax profits were up 11.6% last year, and profit margins were enviably robust. Glaxo also appears to ...

Fortune: MEDICINE/ HEPATITIS C, THE QUIET EPIDEMICupdated: Mon Aug 07 1995 00:01:00

It's a blood-borne disease, transmitted through transfusions, sex, and shared needles. And it's a silent disease; people can go years before developing any symptoms.

Fortune: GLAXO HOLDINGS WHY TO KILL NEW PRODUCT IDEASupdated: Mon Dec 14 1992 00:01:00

IN AN ERA when new products are often vital to corporate success, why do so many companies botch their development? Harvard business school professors Steven Wheelwright and Kim Clark, who have stu...

Fortune: TEN HOT FOREIGN INVESTMENTS You may like to stay home, but your portfolio shouldn't. Global diversification updated: Mon Oct 28 1991 00:01:00

EVEN IF YOU prefer backyard vacations and meat and potatoes, it pays to be cosmopolitan when you're investing. Just as any sound portfolio should spread risk across a number of industries, it makes...

Fortune: DRUGMAKERS UNDER ATTACK . Marketing muscle, patent protection, and a unique relationship with their customers have made them Ameupdated: Mon Jul 29 1991 00:01:00

NO AMERICAN INDUSTRY has ever defied the laws of economic gravity like pharmaceuticals. For the past 30 years the drugmakers of the FORTUNE 500 have enjoyed the fattest profits in big business. The...

Money Magazine: DON'T LOOK BACK, MERCK! GLAXO IS GAINING ON YOUupdated: Fri Mar 01 1991 00:01:00

On the strength of a single best-selling anti-ulcer drug, Zantac, Britain's Glaxo Holdings leaped in 10 years from 25th in pharmaceutical sales among the world's drugmakers to just behind $7.6 bill...

Fortune: TWENTY-FIRST SECURITIES ''It's an earnings-driven stock market,'' says this seasoned Wall Streeter. And since updated: Mon Nov 02 1987 00:01:00

THE BULL MARKET in equities lives,'' says Robert Stovall, the fourth-place finisher in the 1987 Challenge. Stovall, 61, is president of Stovall/Twenty- First Advisers, a subsidiary of Twenty-First ...

We recommend